|
External motivation
|
Introjected motivation
|
Identified motivation
|
---|
β
|
95% CI
|
p value
|
β
|
95% CI
|
p value
|
β
|
95% CI
|
p value
|
---|
Intercept
|
12.45
|
2.96; 21.94
|
0.011
|
5.71
|
−6.01; 17.41
|
0.341
|
7.41
|
−3.85; 18.67
|
0.197
|
Condition
|
0.37
|
−2.49; 3.23
|
0.799
|
− 2.39
|
−6.22; 1.44
|
0.222
|
−0.91
|
−4.42; 2.61
|
0.613
|
Gender
|
1.61
|
−1.82; 5.04
|
0.358
|
0.57
|
−4.09; 5.24
|
0.811
|
−3.76
|
−8.04; 0.52
|
0.085
|
Substance use
|
1.09
|
−1.88; 4.06
|
0.472
|
0.77
|
−3.26; 4.79
|
0.708
|
−0.28
|
−3.97; 3.42
|
0.884
|
Medication adherence baselinea
|
−0.03
|
−0.11; 0.06
|
0.548
|
0.04
|
−0.07; 0.16
|
0.506
|
0.09
|
−0.02; 0.19
|
0.103
|
Motivation baselineb
|
0.43
|
0.25; 0.61
|
< 0.001
|
0.61
|
0.41; 0.81
|
< 0.001
|
0.56
|
0.39; 0.72
|
< 0.001
|
Medication side-effects
|
−0.12
|
−0.54; 0.29
|
0.571
|
−0.11
|
−0.67; 0.46
|
0.714
|
0.34
|
−0.16; 0.84
|
0.181
|
Illness insight
|
−0.29
|
−1.13; 0.54
|
0.486
|
−1.33
|
−2.47; − 0.19
|
0.023
|
−1.65
|
−2.72; − 0.59
|
0.002
|
Medication adherence 12 months
|
−0.03
|
− 0.14; 0.07
|
0.542
|
− 0.02
|
−0.16; 0.12
|
0.796
|
0.02
|
−0.11; 0.15
|
0.711
|
- a Medication adherence in the 4 months prior to baseline bMotivation measured at baseline for each type of motivation